Development of a new management model for oral outpatient chemotherapy featured by concerted interventions by physicians and pharmacists

Development of a new management model for oral outpatient chemotherapy featured by concerted interventions by physicians and pharmacists - Development of a new pharmacists' management model for oral outpatient chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026991

Enrollment

Registered

2017-04-14

Start date

2014-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer Pancreatic cancer Biliary cancer

Interventions

Clinical pharmacist&#39

Lecture for treatment, Counseling, Information for Community pharmacist, Develop a care plan Community pharmacist

Telephone follow up

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients treated with S-1 as a single agent or in combination with other agents, and had to give written consent to participate.

Exclusion criteria

Exclusion criteria: Doctor considers unsuitable

Design outcomes

Primary

Measure	Time frame
To evaluate the feasibility of new model	—

Secondary

Measure	Time frame
To examine if the model makes any effects on adherence, ADEs, and patient's satisfaction	—

Countries

Japan

Contacts

Public ContactReiko Ando Makihara

National Cancer Center Hospital Pharmacy

reando@ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026